SEC Form 4 · accession 0001140361-15-010594
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel K Spiegelman
Officer — EVP, Chief Financial Officer
Period of report
Mar 3, 2015
Accepted (ET)
Mar 5, 2015 · 7:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 3, 2015 | A | 10,500 | $0.00 | A | 79,278 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF2 | $108.36 | Mar 3, 2015 | A | 23,900 | A | Sep 3, 2015 | Mar 2, 2025 | Common Stock | 23,900 | 23,900 | D |
Explanation of responses
- F1Restricted stock units granted on March 3, 2015. Price not applicable.
- F2Option grant vests 6/48ths on September 3, 2015, and 1/48th on the 3rd day of every month thereafter.